Seedat Y K
Department of Medicine, University of Natal Medical School, Durban, Republic of South Africa.
J Cardiovasc Pharmacol. 1990;16 Suppl 7:S67-70.
Hypertension is a major disease in the black population of sub-Saharan Africa and the U.S. The prevalence of hypertension varies from 1-30% of the adult population. Differences in blood pressure (BP) between black and white patients have been documented. In this review, genetic, endocrine, and environmental characteristics, renal physiology, and cardiac function are reviewed. Racial differences in renal physiology and socioeconomic status seem to account for BP differences. Black hypertensive patients in sub-Saharan Africa are prone to cerebral hemorrhage, malignant hypertension leading to uremia, and congestive heart failure, whereas coronary artery disease is uncommon. Responses to hypotensive agents like beta-blockers and angiotensin-converting enzyme inhibitors are poor unless these agents are combined with a thiazide diuretic. Black hypertensive patients respond best to diuretics, vasodilators, or calcium channel blockers. A profiled approach to the treatment of hypertension is suggested.
高血压是撒哈拉以南非洲和美国黑人人群中的一种主要疾病。高血压在成年人口中的患病率从1%到30%不等。已有文献记载黑人和白人患者之间的血压差异。在这篇综述中,对遗传、内分泌和环境特征、肾脏生理学和心脏功能进行了综述。肾脏生理学和社会经济地位的种族差异似乎是血压差异的原因。撒哈拉以南非洲的黑人高血压患者容易发生脑出血、导致尿毒症的恶性高血压和充血性心力衰竭,而冠状动脉疾病并不常见。除非与噻嗪类利尿剂联合使用,否则对β受体阻滞剂和血管紧张素转换酶抑制剂等降压药物的反应较差。黑人高血压患者对利尿剂、血管扩张剂或钙通道阻滞剂反应最佳。建议采用个性化方法治疗高血压。